On-line CME Webcast Teaches on Prostate Cancer Screening

OSUWexnerbloglogo2014 On-line CME Webcast Teaches on Prostate Cancer Screening. On this CME webcast, we’ll be examining the conundrum of prostate cancer screening. Joining our moderator in the studio is urologic oncologist and Assistant Professor of Urology, Dr. Shawn Dason.

 

View a video introduction of this webcast

What you’ll learn in this webcast

As a result of this educational activity, webcast participants will be able to: UNDERSTAND the rationale, benefits, and harms of prostate cancer screening; and DEVELOP an approach for prostate cancer screening in a primary care setting.

You’ll also learn about the following:

  • Prostate cancer risk factors
  • The problem with the PSA
  • False positive PSAs
  • False negative PSAs
  • Interpreting the PSA trajectory over time
  • The urologist’s approach to an elevated PSA
  • Common prostate cancer treatments and their complications

You can find this and many other MedNet21 programs on the OSU – CCME website.

Call our MedNet21 Program Manager at 614.293.3473 for more details about subscribing to MedNet21 as a hospital or as an individual. You can also e-mail him at derrick.freeman@osumc.edu.

CME Webcast Teaches on Pancreatic Cancer

OSUWexnerbloglogo2014 CME Webcast Teaches on Pancreatic Cancer. One out of 64 people in the United States will die of pancreatic cancer; it is the 4th leading cause of cancer death. On this CME webcast, we are going to take a look at pancreatic cancer: its causes, its diagnosis, and its treatment. We’re pleased to welcome today’s guest. Dr. Mary Dillhoff is a surgical oncologist and Assistant Professor of Surgery here at the Ohio State University.

View a video introduction of this webcast

What you’ll learn in this webcast

As a result of this educational activity, webcast participants will be able to: IDENTIFY and learn the types of premalignant pancreas cyst and when surgical referral or further work up is indicated; and DESCRIBE work up and staging or pancreatic cancer and the treatment options.

You’ll also learn about the following:

  • Pancreatic cancer survival
  • Screening for pancreatic cancer
  • Medical management issues after a Whipple procedure
  • Post-op cancer follow up

You can find this and many other MedNet21 programs on the OSU – CCME website.

Call our MedNet21 Program Manager at 614.293.3473 for more details about subscribing to MedNet21 as a hospital or as an individual. You can also e-mail him at derrick.freeman@osumc.edu.

CME Webcast Discusses Macular Degeneration

OSUWexnerbloglogo2014 CME Webcast Discusses Macular Degeneration. On this CME webcast, we’re going to update you on the current approaches to the diagnosis and treatment of macular degeneration. Let me welcome today’s guests. Dr. Matthew Ohr is an Associate Professor of Ophthalmology and the Interim Chairman of the Department of Ophthalmology. And Dr. Fatoumata Yanoga is a retinal specialist and Assistant Professor of Ophthalmology.

View a video introduction of this webcast

What you’ll learn in this webcast

As a result of this educational activity, webcast participants will be able to: REVIEW Characteristics of Age-Related Macular Degeneration; DISCUSS Modifiable Risk Factors that can Lead to Prevention of Disease; DEFINE neovascular macular degeneration; and DISCUSS the diagnosis and management of wet macular degeneration.

You’ll also learn about the following:

  • Risk factors for macular degeneration
  • Prognosis of macular degeneration
  • Screening for macular degeneration in the primary care office
  • Assessing risks when starting a patient on anticoagulation

You can find this and many other MedNet21 programs on the OSU – CCME website.

Call our MedNet21 Program Manager at 614.293.3473 for more details about subscribing to MedNet21 as a hospital or as an individual. You can also e-mail him at derrick.freeman@osumc.edu.

Learn the Latest on Hepatocellular Carcinoma Viewing CME Webcast

OSUWexnerbloglogo2014 Learn the Latest on Hepatocellular Carcinoma Viewing CME Webcast. Here in the United States, the incidence of hepatocellular carcinoma is rising. The way that we approach cancer of the liver has changed over the past 20 years and today on MedNet, we are going to bring you up to date on the epidemiology, screening, diagnosis, and treatment of hepatocellular carcinoma. Joining us today is hepatologist and Assistant Professor of Internal Medicine, Dr. Lanla F. Conteh.

View a video introduction of this webcast

What you’ll learn in this webcast

As a result of this educational activity, webcast participants will be able to: UNDERSTAND the epidemiology of hepatocellular carcinoma in the United States; and RECOGNIZE which patients should be screened for hepatocellular carcinoma.

You’ll also learn about the following:

  • The rising incidence of hepatocellular carcinoma
  • New directions in treatment of hepatocellular carcinoma
  • Imaging test of choice in suspected hepatocellular carcinoma
  • How to biopsy suspected hepatocellular carcinoma
  • Viral hepatitis risk factors for hepatocellular carcinoma
  • Fibrolamellar hepatocellular carcinoma

You can find this and many other MedNet21 programs on the OSU – CCME website.

Call our MedNet21 Program Manager at 614.293.3473 for more details about subscribing to MedNet21 as a hospital or as an individual. You can also e-mail him at derrick.freeman@osumc.edu.

On-line Education Teaches Physicians About Aortic Aneurysms

OSUWexnerbloglogo2014 On-line Education Teaches Physicians About Aortic Aneurysms. Over the past 130 years, there have been remarkable advances in the management of abdominal aortic aneurysms. Joining our moderator to tell us about the current approaches to screening for and managing abdominal aortic aneurysms is the director of the Division of Vascular Surgery as well as Director of the Ohio State University Aortic Center, Professor of Surgery Dr. Timur Sarac.

View a video introduction of this webcast

What you’ll learn in this webcast

As a result of this educational activity, webcast participants will be able to: DESCRIBE the risk factors for abdominal aortic aneurysms; EXPLAIN which demographic groups to screen; and DESCRIBE the outcomes and complications of different methods of aneurysm repair.

You’ll also learn about the following:

  • Screening for abdominal aortic aneurysms
  • Treatment of abdominal aortic aneurysms

You can find this and many other MedNet21 programs on the OSU – CCME website.

Call our MedNet21 Program Manager at 614.293.3473 for more details about subscribing to MedNet21 as a hospital or as an individual. You can also e-mail him at derrick.freeman@osumc.edu.